Angiogenesis and Metabolism: Entwined for Therapy Resistance

被引:49
|
作者
Jimenez-Valerio, Gabriela [1 ]
Casanovas, Oriol [1 ]
机构
[1] Catalan Inst Oncol IDIBELL, ProCURE, Tumor Angiogenesis Grp, Barcelona, Spain
来源
TRENDS IN CANCER | 2017年 / 3卷 / 01期
基金
欧洲研究理事会;
关键词
GLUTAMINE-METABOLISM; CELL METABOLISM; CANCER; EVEROLIMUS; HYPOXIA; PATHWAY; HALLMARKS; GROWTH; TRIAL;
D O I
10.1016/j.trecan.2016.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis and metabolism are entwined processes that permit tumor growth and progression. Blood vessel supply is necessary for tumor survival not only by providing oxygen and nutrients for anabolism but also by removing waste products from cellular metabolism. On the other hand, blocking angiogenesis with antiangiogenic therapies shows clinical benefits in treating several tumor types. Nevertheless, resistance to therapy emerges over time. In this review we discuss a novel mechanism of adaptive resistance involving metabolic adaptation of tumor cells, and we also provide examples of tumor adaptation to therapy, which may represent a new mechanism of resistance in several types of cancer. Thus, targeting this metabolic tumor adaptation could be a way to avoid resistance in cancer patients.
引用
收藏
页码:10 / 18
页数:9
相关论文
共 50 条
  • [1] Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance
    Zarzuela, Laura
    Duran, Raul V.
    Tome, Mercedes
    MOLECULAR ONCOLOGY, 2025, 19 (03) : 592 - 613
  • [2] The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
    Muz, Barbara
    de la Puente, Pilar
    Azab, Feda
    Azab, Abdel Kareem
    HYPOXIA, 2015, 3 : 83 - 92
  • [3] Extracellular vesicles in tumor angiogenesis and resistance to anti-angiogenic therapy
    Ye, Zi-Wu
    Yu, Zi-Li
    Chen, Gang
    Jia, Jun
    CANCER SCIENCE, 2023, 114 (07) : 2739 - 2749
  • [4] Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
    Kondoh, Hiroshi
    Castellvi, Josep
    LLeonart, Matilde Esther
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
    Tu, Zewei
    Wang, Chong
    Hu, Qing
    Tao, Chuming
    Fang, Zhansheng
    Lin, Li
    Lei, Kunjian
    Luo, Min
    Sheng, Yilei
    Long, Xiaoyan
    Li, Jingying
    Wu, Lei
    Huang, Kai
    Zhu, Xingen
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [6] Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective
    Missiaen, Rindert
    Morales-Rodriguez, Francisco
    Eelen, Guy
    Carmeliet, Peter
    VASCULAR PHARMACOLOGY, 2017, 90 : 8 - 18
  • [7] Anti-CD73 therapy impairs tumor angiogenesis
    Allard, Bertrand
    Turcotte, Martin
    Spring, Kathleen
    Pommey, Sandra
    Royal, Isabelle
    Stagg, John
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (06) : 1466 - 1473
  • [8] Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis
    Farhan, Mohd
    Silva, Marta
    Xing Xingan
    Yu Huang
    Zheng, Wenhua
    CELLS, 2020, 9 (07) : 1 - 18
  • [9] Endothelial Metabolism Driving Angiogenesis Emerging Concepts and Principles
    Cantelmo, Anna Rita
    Brajic, Aleksandra
    Carmeliet, Peter
    CANCER JOURNAL, 2015, 21 (04) : 244 - 249
  • [10] Impact of cancer metabolism on therapy resistance - Clinical implications
    Goncalves, Ana Cristina
    Richiardone, Elena
    Jorge, Joana
    Polonia, Barbara
    Xavier, Cristina P. R.
    Salaroglio, Iris Chiara
    Riganti, Chiara
    Vasconcelos, M. Helena
    Corbet, Cyril
    Sarmento-Ribeiro, Ana Bela
    DRUG RESISTANCE UPDATES, 2021, 59